PTC Therapeutics Inc (PTCT)
35.10
-0.27
(-0.76%)
USD |
NASDAQ |
Oct 04, 16:00
35.07
-0.03
(-0.09%)
After-Hours: 20:00
PTC Therapeutics Shareholders Equity (Annual): -818.56M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -818.56M |
| December 31, 2022 | -347.09M |
| December 31, 2021 | 1.438M |
| December 31, 2020 | 481.98M |
| December 31, 2019 | 594.33M |
| December 31, 2018 | 350.73M |
| December 31, 2017 | 156.44M |
| Date | Value |
|---|---|
| December 31, 2016 | 119.58M |
| December 31, 2015 | 226.00M |
| December 31, 2014 | 298.47M |
| December 31, 2013 | 136.54M |
| December 31, 2012 | -19.19M |
| December 31, 2011 | -238.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-818.56M
Minimum
2023
594.33M
Maximum
2019
-17.58M
Average
1.438M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 17.58B |
| BridgeBio Pharma Inc | -1.354B |
| United Therapeutics Corp | 5.985B |
| Voyager Therapeutics Inc | 236.32M |
| Crinetics Pharmaceuticals Inc | 539.11M |